Form 4: USANA Health Sciences Executive Brent Neidig Reports Stock Transactions

Chief Commercial Officer Brent Neidig reports transactions involving USANA Health Sciences Inc. stock, including the vesting and disposal of restricted stock units.

Summary

• Brent Neidig, Chief Commercial Officer of USANA Health Sciences Inc., filed a Form 4 detailing changes in beneficial ownership.
• On February 6, 2025, 2,220 restricted stock units vested and were converted into common stock, followed by the disposal of 1,103 shares to cover tax obligations at a price of $31.21 per share, leaving 1,117 shares.
• On February 7, 2025, 1,402 restricted stock units vested and were converted into common stock, followed by the disposal of 639 shares to cover tax obligations at a price of $30.65 per share, leaving 1,880 shares.
• Following these transactions, Neidig directly owns 23,458 and 22,056 restricted stock units respectively.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are common and are often related to compensation and tax planning. The vesting of restricted stock units is a typical component of executive compensation packages.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the increased number of shares in the market, but the effect is likely minimal.

Key Dates

Keywords

USANA Health Sciences, Brent Neidig, Form 4, Beneficial Ownership, Restricted Stock Units, Stock Transactions, Vesting, Tax Obligations